Humanitarian Business: Crucell Wins $110 Million UNICEF Contract
May 7, 2010 (FinancialWire) — Dutch biopharmaceutical company Crucell N.V. (NASDAQ: CRXL) said it has been awarded an additional $110 million from UNICEF to supply its paediatric vaccine Quinvaxem to the developing world. Paediatric vaccination plays a …